Table 4 Demographics and clinical characteristics of patients with Kawasaki disease shock syndrome and septic shock group (continuous variables were described as median and range)
From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study
KDSS (n=13) | SS (n=29) | P value | |
|---|---|---|---|
Age, (years) | 5.1 (0.5–10.6) | 7.6 (0.3–19.9) | 0.185 |
Male (%) | 46.2% (6/13) | 65.5% (19/29) | 0.237 |
Fever duration (days) | 11 (8–23) | 7 (1–114) | 0.068 |
Total hospital day (days) | 18 (6–31) | 13 (7–225) | 0.419 |
Follow up duration (months) | 10 (1–105) | 2.5 (0–119) | 0.124 |
ICU care (%) | 53.8% (7/13) | 62.1% (18/29) | 0.616 |
ICU care duration (days) | 4 (0–11) | 3 (0–20) | 0.591 |
Inotropic drugs (%) | 92.3% (12/13)§ | 86.2% (25/29) | 0.153 |
Respiratory support | |||
- No support | 30.8% (4/13) | 48.3% (14/29) | 0.289 |
- Oxygen delivery | 53.8% (7/13) | 10.3% (3/29) | 0.005 |
- Mechanical ventilation | 15.4% (2/13) | 41.4%(12/29) | 0.159 |
Mortality (%) | 0.0% (0/13) | 10.3%(3/29) | 0.540 |